Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
In a randomised, placebo controlled, double blind study inosine pranobex was assessed as a possible second line drug in rheumatoid arthritis. Twenty four patients received inosine pranobex (3 g/day) and 26 patients received placebo for up to 24 weeks. Morning stiffness, articular index, grip strengt...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1990
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004071/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1693065/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.49.5.293 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|